Cell Counting Market Share

APAC Market Statistics

The Asian Pacific cell counting market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the increasing cases of cancer. Low blood counts are most frequently a side effect of chemotherapy in cancer patients, which is expected to boost the demand for cell counting in the region. A full cell count can assist assess whether or not a patient's disease will progress under certain conditions. Cell counting is also used for determining primary tumors, circulating tumors, and others. Further, the expanding use of stem cell treatment in nations including China, Japan, India, and others, is also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry is also anticipated to boost market growth during the forecast period. As per data, in Southeast Asia, there were over 150 thousand new cases of breast cancer in 2020.

North American Market Forecast

The North American cell counting market, amongst the market in all the other regions, is projected to grow with the highest CAGR during the forecast period. The growth of the market can be attributed majorly to the growing prevalence of cardiovascular and blood disorders. Almost half of all Americans suffer from cardiovascular disease, which can be brought on by factors including diabetes, smoking, high blood pressure, poor diet, and inactivity. Many risk factors for cardiovascular disease are connected to WBC count, which is anticipated to increase the region's demand for cell counting. For instance, smokers have a greater WBC count, which increases the risk of dying from coronary heart disease. Further, the increasing focus on medical research aimed at enhancing techniques to determine the number of cells in the human body is also anticipated to contribute to the market growth in the region.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2037. The growth of the market can be attributed majorly to the increasing frequency of chronic illnesses. The use of biologics to treat chronic illnesses is becoming more popular in the region. The usage of cell counting tools, including flow cytometers and spectrophotometers, helps in regulating the cell content in biologics. In addition, immune health in patients is also indicated by their CD4 cell count. Further, the rising government funding and efforts for cancer research, are also anticipated to contribute to the market growth in the region. In addition, the surging adoption of cell counting devices in various areas of research such as immunology, cancer biology, and neuroscience in the region, is also anticipated to boost the market growth during the forecast period.